Company Filing History:
Years Active: 2022
Title: Leonardo De Maria: Innovator in Protein Conjugates
Introduction
Leonardo De Maria is a notable inventor based in Partille, Sweden. He has made significant contributions to the field of protein conjugates, particularly in the development of oligomer extended insulin-Fc conjugates. His work is aimed at improving treatments for metabolic disorders.
Latest Patents
Leonardo holds 1 patent for his invention titled "Oligomer extended insulin-Fc conjugates." This invention focuses on oligomer extended insulins that are covalently attached to Fc monomer polypeptides. These conjugates are designed for use in treating metabolic disorders and include methods for their production. The invention also introduces novel Fc fragments and intermediate products, which are essential for synthesizing the oligomer extended insulin-Fc conjugates. Furthermore, it encompasses pharmaceutical compositions that utilize these conjugates for treating or preventing medical conditions related to metabolic disorders.
Career Highlights
Leonardo is currently associated with Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to contribute to innovative solutions in diabetes care and other metabolic conditions. His expertise in protein conjugates is instrumental in advancing the company's research and development efforts.
Collaborations
Leonardo has collaborated with esteemed colleagues such as Tina Moeller Tagmose and Peter Madsen. These collaborations enhance the research environment and foster innovation within the field.
Conclusion
Leonardo De Maria's work in the development of oligomer extended insulin-Fc conjugates represents a significant advancement in the treatment of metabolic disorders. His contributions to the field of protein conjugates are paving the way for new therapeutic options.